F-group (family)

2003.1.1.22 GFO_IDH_MocA

Ligands and drugs

879
Member domains
413
with ligand contacts (≤ 4 Å)
47.0% of members
356
with DrugDomain annotations
40.5% of members
337
with a DrugBank compound
38.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 2003.1.1.22 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB14128NADNadide114
DB02338NDPNADPH61
DB03461NAPNicotinamide adenine dinucleotide phosphate56
DB00157NAINADH55
DB02379BGCBeta-D-Glucose10
DB13178INSInositol9
DB01638SORSorbitol6
DB03345BMEMercaptoethanol5
DB08845AKGOxogluric acid4
DB031062H3scyllo-inositol3
DB03590API2,6-Diaminopimelic Acid3
DB00139SINSuccinic acid2
DB09459TLAL-tartaric acid2
DB03389XYSalpha-D-Xylopyranose1
DB03567A2Galpha-N-Acetyl-D-galactosamine1

Most frequently bound compounds

PDB ligandNameDomains in contact
NADNICOTINAMIDE-ADENINE-DINUCLEOTIDE147
NAPNADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE65
NDPNADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE64
NAI1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE39
CLCHLORIDE ION22
HP7(2S,3S,4R,5R,6R)-5-acetamido-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-3,4-dihydroxy-oxane-2-carboxylic acid21
NAmetalSODIUM ION14
MGmetalMAGNESIUM ION13
BGCbeta-D-glucopyranose10
INS1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE9
8S0L-glucono-1,5-lactone7
API2,6-DIAMINOPIMELIC ACID7
R7Rsulfoquinovose6
SORsorbitol6
XYPbeta-D-xylopyranose6
A2G2-acetamido-2-deoxy-alpha-D-galactopyranose5
ISE(2R,3S,4s,5R,6S)-2,3,4,5,6-pentahydroxycyclohexanone5
TLO5'-O-[(S)-hydroxy{[(S)-hydroxy(phenoxy)phosphoryl]oxy}phosphoryl]thymidine5
AKG2-OXOGLUTARIC ACID4
BLABILIVERDINE IX ALPHA4